Literature DB >> 9125650

Effect of ursodeoxycholic acid on chronic intrahepatic cholestasis due to sarcoidosis.

H Bécheur1, H Dall'osto, G Chatellier, M C Charton-Bain, J M Aubertin, A Attar, F Bloch, J P Petite.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9125650     DOI： 10.1023/a:1018816214640

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN： 0163-2116            Impact factor:   3.199


× No keyword cloud information.
  13 in total

1.  Hepatic expression of class I and class II major histocompatibility complex molecules in primary biliary cirrhosis: effect of ursodeoxycholic acid.

Authors:  Y Calmus; P Gane; P Rouger; R Poupon
Journal:  Hepatology       Date:  1990-01       Impact factor: 17.425

2.  The n-of-1 randomized controlled trial: clinical usefulness. Our three-year experience.

Authors:  G H Guyatt; J L Keller; R Jaeschke; D Rosenbloom; J D Adachi; M T Newhouse
Journal:  Ann Intern Med       Date:  1990-02-15       Impact factor: 25.391

3.  Chronic cholestasis in hepatic sarcoidosis with clinical features resembling primary biliary cirrhosis. Report of two cases.

Authors:  J Pereira-Lima; F Schaffner
Journal:  Am J Med       Date:  1987-07       Impact factor: 4.965

4.  Sarcoidosis and chronic hepatic disease: a clinical and pathologic study of 20 patients.

Authors:  W C Maddrey; C J Johns; J K Boitnott; F L Iber
Journal:  Medicine (Baltimore)       Date:  1970-09       Impact factor: 1.889

Review 5.  Hepatic sarcoidosis with portal hypertension. A report of seven cases with a review of the literature.

Authors:  D Valla; H Pessegueiro-Miranda; C Degott; D Lebrec; B Rueff; J P Benhamou
Journal:  Q J Med       Date:  1987-06

6.  The liver in sarcoidosis.

Authors:  E Lehmuskallio; M Hannuksela; H Halme
Journal:  Acta Med Scand       Date:  1977

7.  Immunomodulatory effects of ursodeoxycholic acid on immune responses.

Authors:  M Yoshikawa; T Tsujii; K Matsumura; J Yamao; Y Matsumura; R Kubo; H Fukui; S Ishizaka
Journal:  Hepatology       Date:  1992-08       Impact factor: 17.425

8.  Value of liver biopsy in sarcoidosis.

Authors:  H D Hercules; N M Bethlem
Journal:  Arch Pathol Lab Med       Date:  1984-10       Impact factor: 5.534

9.  Portal hypertension complicating sarcoid liver disease: case report and review of the literature.

Authors:  H Tekeste; F Latour; R E Levitt
Journal:  Am J Gastroenterol       Date:  1984-05       Impact factor: 10.864

10.  Chronic intrahepatic cholestasis due to sarcoidosis.

Authors:  N M Bass; A K Burroughs; P J Scheuer; D G James; S Sherlock
Journal:  Gut       Date:  1982-05       Impact factor: 23.059
View more
  5 in total

1.  Granulomatous Liver Disease.

Authors: 
Journal:  Curr Treat Options Gastroenterol       Date:  2000-12

Review 2.  Effect of ursodeoxycholic acid on granulomatous liver disease due to sarcoidosis.

Authors:  Bader Alenezi; Esther Lamoureux; Lesley Alpert; Andrew Szilagyi
Journal:  Dig Dis Sci       Date:  2005-01       Impact factor: 3.199

Review 3.  Extrapulmonary manifestations of sarcoidosis.

Authors:  Deepak A Rao; Paul F Dellaripa
Journal:  Rheum Dis Clin North Am       Date:  2013-03-13       Impact factor: 2.670

Review 4.  Hepatic Sarcoidosis.

Authors:  Micheal Tadros; Faripour Forouhar; George Y Wu
Journal:  J Clin Transl Hepatol       Date:  2013-12-15

Review 5.  Management of extrapulmonary sarcoidosis: challenges and solutions.

Authors:  Khalid Al-Kofahi; Peter Korsten; Christian Ascoli; Shanti Virupannavar; Mehdi Mirsaeidi; Ian Chang; Naim Qaqish; Lesley A Saketkoo; Robert P Baughman; Nadera J Sweiss
Journal:  Ther Clin Risk Manag       Date:  2016-11-07       Impact factor: 2.423
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.